<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03386864</url>
  </required_header>
  <id_info>
    <org_study_id>5263R</org_study_id>
    <nct_id>NCT03386864</nct_id>
  </id_info>
  <brief_title>Metabolic Determinants of Cardiac Function</brief_title>
  <official_title>Metabolic Determinants of Cardiac Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of cardiac energy metabolism in patients with impaired glucose tolerance
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Insulin resistance, hepatocellular lipids (HCL) and plasma concentrations of free fatty acids
      (FFA) are predictors of heart failure, the leading cause of mortality in patients suffering
      from type 2 diabetes mellitus (T2DM). Epidemiological data suggest that diabetic
      cardiomyopathy (DC) presents as ventricular dysfunction in patients with T2DM independent of
      coronary artery disease. The underlying cellular mechanisms are poorly understood. Reduced
      mitochondrial activity and insulin resistance of skeletal muscle relates to liver steatosis,
      possibly due to higher substrate flux to the liver. High oxidation rates in the liver result
      in oxidative stress, damage of mitochondria and apoptosis. The investigators hypothesize that
      (i) HCL and impaired liver energy metabolism correlate with ventricular dysfunction, (ii)
      impaired glucose uptake and mitochondrial capacity in skeletal muscle relates to enhanced
      oxidative capacity, oxidative stress and lipid deposition in heart tissue (iii) reduced
      myocardial oxidative capacity limits recovery of myocardial function in patients with acute
      heart failure.

      The investigators aim to assess (i) liver energy metabolism and heart function, (ii)
      respiration and lipid metabolites in skeletal muscle and heart tissue in humans with advanced
      heart failure and (iii) the prognostic impact of these factors in humans with acute heart
      failure.

      This study will improve the understanding of mechanisms underlying the development of DC and
      the identification of patients at risk for poor outcome in heart failure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mitochondrial oxygen flux</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>measured using high resolution respirometry. Unit: pmol/(s*mg)</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Heart Failure</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin Resistant</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 Diabetes</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Myocardial biopsies blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing myocardial biopsy, left ventricular assist device implantation or heart
        transplantation for medical reasons
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 20 and ≤85 years

          -  myocardial biopsy for medical reason

        Exclusion Criteria:

          -  acute infection

          -  autoimmune disease

          -  pregnancy

          -  cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julia Szendroedi, PD Dr. med, PhD</last_name>
    <phone>+492113382203</phone>
    <email>julia.szendroedi@ddz.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ralf Westenfeld, PD Dr. med</last_name>
    <phone>+4921118800</phone>
    <email>ralf.westenfed@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Diabetes Center</name>
      <address>
        <city>Düsseldorf</city>
        <state>NRW</state>
        <zip>40223</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Szendroedi, PD Dr. med., PhD</last_name>
      <phone>+492113382203</phone>
      <email>Julia.szendroedi@ddz.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Daniel Scheiber, Dr. med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2017</study_first_posted>
  <last_update_submitted>December 28, 2017</last_update_submitted>
  <last_update_submitted_qc>December 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Diabetes Center</investigator_affiliation>
    <investigator_full_name>julia szendrödi</investigator_full_name>
    <investigator_title>PD Dr. med. Julia Szendroedi, PhD</investigator_title>
  </responsible_party>
  <keyword>Heart Failure, Diabetes Mellitus, Mitochondrial Respiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

